Table: Wakamoto Pharm -2021/22 parent results

Wakamoto Pharmaceutical

16/05/2022 07:00

May 16 (Reuters)- 
          Wakamoto Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2022    Mar 31, 2021   Mar 31, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           8.38            8.90           8.50                  
                               (-18.5 pct)    (+1.4 pct)               
  Operating    loss 13 mln    loss 754 mln      90 mln                 
  Recurring      72 mln       loss 604 mln      110 mln                
                                              (+52.2 pct)              
  Net            238 mln      loss 601 mln      150 mln                
                                              (-37.1 pct)              
  EPS           6.87 yen     loss 17.34 yen    4.32 yen                
  Ann Div          NIL             NIL                                 
  -Q2 Div          NIL             NIL                                 
  -Q4 Div          NIL             NIL                                 
  
  NOTE - Wakamoto Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4512.T